Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates. [electronic resource]
Producer: 20060413Description: 2328-37 p. digitalISSN:- 0008-5472
- Animals
- Antigens, CD -- biosynthesis
- Antineoplastic Agents -- administration & dosage
- Apoptosis -- drug effects
- CD27 Ligand
- Carcinoma, Renal Cell -- drug therapy
- Cell Cycle -- drug effects
- Humans
- Immunoconjugates -- immunology
- Immunohistochemistry
- Kidney Neoplasms -- drug therapy
- Lymphocyte Activation
- Membrane Proteins -- biosynthesis
- Mice
- Mice, Nude
- Microtubules -- drug effects
- Oligopeptides -- administration & dosage
- Phenylalanine -- analogs & derivatives
- RNA, Messenger -- biosynthesis
- Tumor Necrosis Factors -- biosynthesis
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.